# US 2018/0021322 A1 · 1-arylalkyl-4-acylaminopiperidine compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021322 A1
- Document ID: US20180021322A1
- Status: Published application
- Kind: A1
- Application number: 15/709,394
- Filed: 2017-09-19
- Published: 2018-01-25
- Earliest claimed: 2014-08-22
- Assignees: Arizona Board of Regents on Behalf of the University of Arizona
- Applicants: Arizona Board of Regents On Behalf of the University of Arizona
- Inventors: Ruben S. Vardanyan; Victor J. Hruby
- Web page: https://patentgrep.com/patent/US20180021322A1

## CPC

- C07D 211/58: attached in position 4
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 31/4465: only substituted in position 4
- A61K 31/4468: having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A61K 31/451: having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A61P 25/00: Drugs for disorders of the nervous system
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 407/12: linked by a chain containing hetero atoms as chain links
- C07D 409/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a compound of the formula: wherein ring Z is a 5-, 6- or 7-membered ring; R1 is C1-10 alkyl, C1-10 haloalkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heteroaralkyl; R2 is C1-10 alkylene; and Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)-X1, wherein X1 is —OR3 or —NR4R5, where each of R3, R4 and R5 is H or C1-10 alkyl. The present invention also provides a method for using compound of Formula I to treat a wide variety of clinical conditions.

## Claims

### Claim 1

A compound of the formula:
wherein
ring Z is a 5-, 6- or 7-membered ring;
R1 is C1-10 alkyl, C1-10 haloalkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heteroaralkyl;
R2 is C1-10 alkylene; and
Y is optionally substituted aryl, optionally substituted heteroaryl, or a moiety of the formula —C(═O)-X1, wherein X1 is —OR3 or —NR4R5, where each of R3, R4 and R5 is H or C1-10 alkyl.

### Claim 2 (depends on 1)

The compound according to claim 1, wherein R1 is selected from the group consisting of ethyl, 7-bromoheptyl, optionally substituted fur-2-yl, optionally substituted fur-3-yl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, and optionally substituted phenyl.

### Claim 3 (depends on 2)

The compound according to claim 2, wherein R1 is optionally substituted fur-2-yl, optionally substituted fur-3-yl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl or optionally substituted phenyl.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein R2 is C1-C4 alkylene.

### Claim 5 (depends on 1)

The compound according to claim 1, wherein Y is selected from the group consisting of optionally substituted phenyl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, optionally substituted fur-2-yl, optionally substituted fur-3-yl, a moiety of the formula —C(═O)—OR3, where R3 is C1-C10 alkyl, and a moiety of the formula —C(═O)NRaRb, where each of Ra and Rb is independently H or C1-C10 alkyl.

### Claim 6 (depends on 5)

The compound according to claim 5, wherein Y is optionally substituted phenyl, optionally substituted thiophen-2-yl, optionally substituted thiophen-3-yl, optionally substituted fur-2-yl or optionally substituted fur-3-yl.

### Claim 7 (depends on 1)

The compound according to claim 1 of the formula:
wherein R1, R2 and Y are those defined in claim 1.

### Claim 8 (depends on 1)

The compound according to claim 1 of the formula:
wherein R1, R2 and Y are those defined in claim 1.

### Claim 9 (depends on 1)

A method for treating hemorrhagic shock, nicotine withdrawal symptoms, gastrointestinal side effects of opioids, cancer therapy, epithelial wounds, herpes zoster infection, or opioid-induced pruritus in a subject, said method comprising administering a therapeutically effective amount of a compound of claim 1.

### Claim 10 (depends on 1)

A method for treating a subject suffering from Raynaud's disease, hypertension, scleroderma, anxiety and panic disorders, or dyskinesia associated with Parkinson's disease, said method comprising administering a therapeutically effective amount of a compound of claim 1.
